![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
-Induced Increases in Enteric Epithelial PermeabilityIntestinal Disease Research Programme (D.M.M., J.L.W., A.W., J.C., D.P., P.M.J.C., J.L.), Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; and Department of Surgical and Gastroenterological Sciences, University Hospital Padova, Italy (V.D.L.)
The epithelial lining of mucosal surfaces acts as a barrier to regulate the entry of antigen and pathogens. Nowhere is this function of the contiguous epithelium more important than in the gut, which is continually exposed to a huge antigenic load and, in the colon, an immense commensal microbiota. We assessed the intracellular signaling events that underlie interferon (IFN)
-induced increases in epithelial permeability using monolayers of the human colonic T84 epithelial cell line. Confluent epithelial monolayers on semipermeable supports were treated with IFN
(20 ng/ml), and barrier function was assessed 48 h later by measuring transepithelial electrical resistance (TER: reflects passive ion flux), fluxes of 51Cr-EDTA and horseradish peroxidase (HRP), and transcytosis of noninvasive, nonpathogenic Escherichia coli (strain HB101). Exposure to IFN
decreased barrier function as assessed by all four markers. The phosphatidylinositol 3'-kinase (PI-3K) inhibitors, LY294002 [2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride] and wortmannin, did not affect baseline permeability characteristics but completely blocked the drop in TER, increased fluxes of 51Cr-EDTA and HRP, and significantly reduced E. coli transcytosis evoked by IFN
. In addition, use of the pan-protein kinase C (PKC) inhibitor, bisindolylmaleimide I (5 µM), but not rottlerin (blocks PKC
), partially ameliorated the drop in TER and inhibited increased E. coli transcytosis. Addition of the PI-3K and PKC inhibitors to epithelia 6 h after IFN
exposure still prevented the increase in paracellular permeability but not E. coli transcytosis. Thus, IFN
-induced increases in epithelial paracellular and transcellular permeability are critically dependent on PI-3K activity, which may represent an epithelial-specific target to treat immune-mediated loss of barrier function.
Address correspondence to: Dr. Derek M. McKay, Gastrointestinal Research Group, Department of Physiology and Biophysics, 1877 HSc, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta, Canada T2N 4N1. E-mail: dmckay{at}ucalgary.ca
This article has been cited by other articles:
![]() |
K. Lewis, J. Caldwell, V. Phan, D. Prescott, A. Nazli, A. Wang, J. D. Soderholm, M. H. Perdue, P. M. Sherman, and D. M. McKay Decreased epithelial barrier function evoked by exposure to metabolic stress and nonpathogenic E. coli is enhanced by TNF-{alpha} Am J Physiol Gastrointest Liver Physiol, March 1, 2008; 294(3): G669 - G678. [Abstract] [Full Text] [PDF] |
||||